Ligand Pharmaceuticals Incorporated (LGND) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for…
Source: Yahoo Finance
Sector & Industry
Ligand Pharmaceuticals Incorporated operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Ligand Pharmaceuticals Incorporated at a Glance
| Company | Ligand Pharmaceuticals Incorporated |
| Ticker | LGND |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $285.60 |
| Market cap | $5.69B |
| P/E ratio (trailing) | 29.41 |
| EPS (trailing) | $9.71 |
| 52-week high | $326.63 |
| 52-week low | $161.82 |
| Dividend yield | — |
| Ex-dividend date (last paid) | 02 Jul 2010 |
| Beta | 0.98 |
| Return on equity (ROE) | 21.96% |
| Debt-to-equity | 116.94% |
| Average volume | 356,458 |
| Shares outstanding | 19.94M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 47 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Ligand Pharmaceuticals Incorporated's current P/E ratio?
- Ligand Pharmaceuticals Incorporated (LGND) has a trailing P/E ratio of 29.41 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Ligand Pharmaceuticals Incorporated's market capitalisation?
- Ligand Pharmaceuticals Incorporated's market cap is $5.69B based on our latest snapshot. See how it ranks by market cap →
- What is LGND's 52-week range?
- Over the past 52 weeks, LGND has traded between $161.82 and $326.63. What does the 52-week range mean? →
- How volatile is Ligand Pharmaceuticals Incorporated compared to the market?
- Ligand Pharmaceuticals Incorporated has a beta of 0.98, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Ligand Pharmaceuticals Incorporated pay a dividend?
- Ligand Pharmaceuticals Incorporated does not currently pay a dividend according to our latest data.
- What exchange is LGND listed on?
- LGND is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Ligand Pharmaceuticals Incorporated in?
- Ligand Pharmaceuticals Incorporated is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →